Last updated: July 18, 2026
- Case: MSP Recovery Claims, Series LLC v. AbbVie Inc., 1:18-cv-00892 (E.D. Missouri).
- Core allegation type: Medicare Secondary Payer (MSP) “conditional payment” reimbursement recovery under the Medicare Secondary Payer statute, seeking to recover amounts allegedly paid by Medicare for which Medicare asserts it was a secondary payer due to the defendant’s product-related liability.
- Procedural status: No complete, verifiable litigation outcome details (dismissal/settlement/judgment date, claims resolved, and dispositive rulings) are included in the provided information. Without case-record specifics, a complete litigation summary and analysis cannot be produced to a high-integrity standard.
What is MSP Recovery Claims, Series LLC v. AbbVie Inc. (1:18-cv-00892) about?
The naming format indicates a Medicare “MSP” reimbursement enforcement posture by MSP Recovery Claims, Series LLC against AbbVie Inc. under the MSP framework. MSP cases of this type typically involve Medicare seeking reimbursement for conditional payments made for covered medical services that, under the theory pleaded, should have been borne by a primary payer.
What Medicare Secondary Payer theory is typically pleaded in MSP Recovery cases?
These suits generally allege:
- Medicare made conditional payments for medical services.
- The defendant’s conduct created a primary payer obligation (often framed through settlement, judgment, or product-liability-related liability).
- MSP Recovery seeks reimbursement and/or statutory damages, with an emphasis on Medicare’s right to recover.
What claims were asserted in MSP Recovery Claims, Series LLC v. AbbVie Inc.?
Not determinable from the provided inputs. A litigation-quality summary requires the asserted causes of action and the specific legal theories (e.g., statutory reimbursement, whether private plaintiff standing is asserted, pleading of conditional payments, and any theory tied to beneficiaries or settlements).
What happened procedurally in 1:18-cv-00892 (motions, rulings, discovery)?
Not determinable from the provided inputs. A reliable procedural timeline depends on docket entries (e.g., motions to dismiss, stay/transfer activity, summary judgment motions, any appellate activity, and dates of orders).
How do MSP cases against pharma (including AbbVie) typically get decided at motion-to-dismiss?
Not determinable for this specific case without the order text or docket record. In MSP reimbursement litigation involving pharmaceutical defendants, motion-to-dismiss rulings often turn on:
- Standing and statutory cause of action for the plaintiff entity.
- Adequacy of allegations that Medicare was a secondary payer.
- Plausibility of a “primary payment” trigger tied to the defendant’s conduct.
- Whether claims are barred by preemption, jurisdictional defects, or failure to meet statutory prerequisites.
What is the likely settlement and remedies posture in MSP Recovery actions?
Not determinable for this docket without settlement documentation, order terms, or final judgment details. Remedies in MSP cases commonly include reimbursement of conditional payments and may include statutory damages and interest, but the exact posture in this case cannot be stated from the provided information.
How strong is the AbbVie defense posture in MSP Recovery actions?
Not determinable for this specific case without the briefing and rulings. Defense themes across MSP pharma litigation can include:
- Denying primary payer responsibility.
- Attacking the causal link between alleged defendant liability and Medicare’s conditional payments.
- Challenging plaintiff’s ability to assert MSP reimbursement claims for particular payment categories.
- Contesting sufficiency of “conditional payment” proof at the pleading stage.
What patent and regulatory issues are implicated by AbbVie’s product in MSP litigation?
Not determinable from the provided inputs. This docket number alone does not identify the AbbVie product, the specific beneficiary cohort, or how the complaint connects the alleged primary payer duty to a particular product and label-driven regimen.
What is the impact of any prior MDL or coordinated MSP litigation on 1:18-cv-00892?
Not determinable without docket history. MSP cases are sometimes consolidated or coordinated depending on jurisdiction and specific procedural posture; this cannot be stated without record verification.
Is there related litigation for AbbVie in MSP Recovery cases (other dockets)?
Not determinable from the provided inputs. A litigation map requires cross-docket identification and outcomes.
How does this case compare with other MSP Recovery v. pharma defendants?
Not determinable at the level of actionable comparative analysis. Comparison needs specifics: which statutory sections, which payment categories, whether any dismissal was granted, and final outcomes.
What are the commercial and exposure implications for AbbVie if MSP Recovery claims succeed?
Not determinable from the provided inputs. Exposure depends on:
- Medicare conditional payment amounts at issue.
- Whether a settlement cap or release scope exists.
- Whether the case resolves on a class or aggregation theory or remains limited to identified claims.
Key Takeaways
- The case is an MSP Medicare Secondary Payer reimbursement action brought by MSP Recovery Claims, Series LLC against AbbVie Inc. under 1:18-cv-00892 in E.D. Missouri.
- The provided information does not include the docket outcomes, dispositive rulings, settlement/judgment terms, or operative-complaint claim details needed to produce a complete litigation summary and business-useful legal analysis.
FAQs
- What evidence do MSP Recovery plaintiffs typically rely on to prove Medicare conditional payments in reimbursement actions?
- What standing arguments do defendants raise in MSP Recovery “private right of action” theories?
- When do MSP cases get dismissed for pleading insufficiency versus resolved on summary judgment?
- How do settlement releases and consent decrees affect ongoing MSP reimbursement claims?
- What jurisdiction-specific factors in the Eastern District of Missouri most often drive MSP case outcomes?
References
- MSP Recovery Claims, Series LLC v. AbbVie Inc., No. 1:18-cv-00892 (E.D. Mo.).
